Impact of red blood cell transfusion on oxygen transport and metabolism in patients with sepsis and septic shock: a systematic review and meta-analysis

ABSTRACT

Red blood cell transfusion is thought to improve cell respiration during septic shock. Nevertheless, its acute impact on oxygen transport and metabolism in this condition remains highly debatable. The objective of this study was to evaluate the impact of red blood cell transfusion on microcirculation and oxygen metabolism in patients with sepsis and septic shock. We conducted a search in the MEDLINE^®, Elsevier and Scopus databases. We included studies conducted in adult humans with sepsis and septic shock. A systematic review and meta-analysis were performed using the DerSimonian and Laird random-effects model. A p value < 0.05 was considered significant. Nineteen manuscripts with 428 patients were included in the analysis. Red blood cell transfusions were associated with an increase in the pooled mean venous oxygen saturation of 3.7% (p < 0.001), a decrease in oxygen extraction ratio of -6.98 (p < 0.001) and had no significant effect on the cardiac index (0.02L/minute; p = 0,96). Similar results were obtained in studies including simultaneous measurements of venous oxygen saturation, oxygen extraction ratio, and cardiac index. Red blood cell transfusions led to a significant increase in the proportion of perfused small vessels (2.85%; p = 0.553), while tissue oxygenation parameters revealed a significant increase in the tissue hemoglobin index (1.66; p = 0.018). Individual studies reported significant improvements in tissue oxygenation and sublingual microcirculatory parameters in patients with deranged microcirculation at baseline. Red blood cell transfusions seemed to improve systemic oxygen metabolism with apparent independence from cardiac index variations. Some beneficial effects have been observed for tissue oxygenation and microcirculation parameters, particularly in patients with more severe alterations at baseline. More studies are necessary to evaluate their clinical impact and to individualize transfusion decisions.

Keywords:
Sepsis; Shock, septic; Erythrocyte transfusion; Oxygenation; Oxygen consumption; Microcirculation; Spectroscopy, near-infrared

RESUMO

Considera-se que a transfusão de eritrócitos melhora a respiração celular durante o choque séptico. Contudo, seu impacto agudo no transporte e no metabolismo de oxigênio nessa condição ainda é amplamente debatido. O objetivo deste estudo foi avaliar o impacto da transfusão de eritrócitos na microcirculação e no metabolismo do oxigênio em pacientes com sepse e choque séptico. Conduzimos um levantamento nas bases de dados MEDLINE^®, Elsevier e Scopus. Incluímos estudos realizados com seres humanos adultos com sepse e choque séptico. Realizamos uma revisão sistemática e metanálise com utilização do modelo de efeitos aleatórios de DerSimonian e Laird. Consideramos significante valor de p < 0,05. Incluíram-se na análise 19 manuscritos, correspondentes a 428 pacientes. As transfusões de eritrócitos se associaram com aumento de 3,7% na média combinada de saturação venosa mista de oxigênio (p < 0,001), diminuição de razão de extração de oxigênio de -6,98 (p < 0,001) e nenhum efeito significante no índice cardíaco (0,02 L/minuto; p = 0,96). Obtiveram-se resultados similares em estudos que incluíram mensurações simultâneas de saturação venosa mista de oxigênio, razão de extração de oxigênio e índice cardíaco. As transfusões de eritrócitos levaram a aumento significante na proporção de pequenos vasos perfundidos (2,85%; p = 0,553), enquanto os parâmetros de oxigenação tissular revelaram aumento significante no índice de hemoglobina tissular (1,66; p = 0,018). Estudos individuais relataram melhoras significantes na oxigenação tissular e nos parâmetros microcirculatórios sublinguais em pacientes com microcirculação alterada na avaliação inicial. A transfusão de eritrócitos pareceu melhorar o metabolismo sistêmico de oxigênio com aparente independência de variações no débito cardíaco. Observaram-se alguns efeitos benéficos para a oxigenação tissular e parâmetros microcirculatórios, em particular em pacientes com alterações iniciais mais graves. São necessários mais estudos para avaliar seu impacto clínico e individualizar as decisões relativas à transfusão.

Descritores:
Sepse; Choque séptico; Transfusão de eritrócitos; Oxigenação; Consumo de oxigênio; Microcirculação; Espectroscopia de luz próxima ao infravermelho

INTRODUCTION

Anemia is a common condition in critically ill patients.⁽¹⁾ Multiple mechanisms have been implicated in its development, many of which are unrelated to active bleeding.^(1-4) Low hemoglobin (Hb) levels are generally related to increased morbidity⁽¹⁾ and mortality,⁽²⁾ probably as a consequence of the metabolic imbalance between oxygen demands and supply and the sustained hyperadrenergic compensatory response. This is why allogeneic red blood cell (RBC) transfusions are used to treat moderate anemia, aiming to increase the oxygen-carrying capacity to the tissues and thus to meet cellular metabolic demands. However, some evidence suggests that RBC transfusion can be harmful,⁽³⁾ while conservative transfusion strategies lead to similar or even better clinical outcomes than liberal transfusion practices,^(5-10) thus suggesting that moderate or even low Hb levels are apparently well tolerated in humans without significant comorbidities and during more stable phases of disease.

Red blood cell transfusions might increase the risk of harm in patients with normal oxygen metabolism.^(11-13) Thus, guiding transfusions by metabolic or physiological variables would be more plausible than transfusing RBCs and aiming at a predetermined Hb level. However, Hb levels are habitually used as a trigger and target for RBC transfusions in clinical practice,^(5-10) assuming that maintaining Hb levels should ensure adequate oxygen transport to tissues. Nevertheless, triggering RBC transfusion by only Hb levels could be misleading since oxygen delivery to the tissues should be adapted according to the metabolic state and clinical condition.⁽¹⁴⁾ Conversely, microcirculatory blood flow distribution and tissue oxygen variables could better guide RBC transfusions, although early goal-directed therapy protocols, including RBC transfusion, have yielded contradictory clinical results in sepsis and septic shock.^(15-18)

There is a paucity of data evaluating the effects of RBC transfusion on metabolic or tissue oxygen-derived parameters and microvascular blood flow variables, despite the large number of patients included in studies evaluating its clinical impact.^(19,20) Thus, we proposed this systematic review and meta-analysis to evaluate the impact of RBC transfusions on oxygen balance, tissue oxygenation and microcirculatory blood flow in patients with septic shock independently of the trigger or transfusion strategy used.

METHODS

We conducted a systematic review and meta-analysis following the Cochrane recommendations⁽²¹⁾ and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines⁽²²⁾ with the PICO strategy: patients: adults admitted to intensive care units with diagnoses of sepsis or septic shock; intervention: RBC transfusion; comparison: usual care of these septic patients before RBC transfusions; outcome: pooled mean difference of mixed venous oxygen saturation (SvO₂), oxygen extraction ratio (O₂ER), cardiac index, near infrared spectroscopy (NIRS) parameters and sublingual microcirculation parameters by orthogonal polarization spectral (OPS) or side streamdark field (SDF) techniques before and after transfusion. The PRISMA checklist for systematic reviews and meta-analyses is provided in table 1S (Supplementary material).

Study selection

Studies were included if they were performed in adult humans (aged 18 years or older) admitted to intensive care units for sepsis or septic shock without language restrictions. Studies were excluded if they were performed in healthy subjects, patients with hematologic diseases, Jehovah Witnesses or other patients who refused RBC transfusions. Studies performed for hemodilution analysis without transfusions, retransfusions or autotransfusions were also excluded.

Studies obtained for this systematic review reported data before and after RBC transfusions (quasi-experimental design) and therefore were included in the analysis. There were no randomized controlled trials retrieved through the search strategy. Case reports and medical communications were excluded.

Outcomes

The main outcomes were the pooled mean differences in SvO₂, O₂ER, and cardiac index before and after transfusion. Detailed descriptions of each variable are presented in table 2S (Supplementary material). In addition, NIRS parameters (mean thenar tissue oxygenation - StO₂%, tissue hemoglobin index - THI, thenar tissue oxygen saturation upslope of the reperfusion phase, thenar tissue oxygen saturation downslope), and sublingual microcirculation parameters (proportion of perfused small vessels - PPV, perfused small vessel density) were evaluated.

Search strategy

Systematic search strategies followed established Cochrane and PRISMA recommendations. The literature search was performed using the National Center for Biotechnology Information (NCBI) and Elsevier databases from inception to July 2019. We used combined medical subject headings (MeSH) terms related to the intervention of interest (blood transfusions, RBC, erythrocyte transfusion) and outcomes of interest (SvO₂, venous oxygen saturation, oxygen consumption, and microcirculation).

Data collection process

Two investigators reviewed all of the titles and abstracts identified through systematic search strategies. Relevant titles or abstracts were retrieved as full texts. Articles selected for full-text review were independently reviewed by two investigators who determined their eligibility. Disagreements were resolved by a third reviewer.

The following information was extracted using a standardized data form: authors, year of publication, journal of publication, institution wherein the work was performed, study design, inclusion and exclusion criteria, sample size, clinical characteristics (Acute Physiology and Chronic Health Evaluation II - APACHE - II score, main pathology, transfusion trigger, number of RBC received), and clinical information regarding the outcomes of interest. All of the information was entered into an electronic database.

Risk of bias

The internal validity of each study included in this systematic review was evaluated for bias according to the proposed evidence level of individual studies (ELIS) framework.⁽²³⁾ Studies were classified from one (high quality or low risk of bias) to four (low quality or high risk of bias) according to study type, research design, and assessment of strength and limitations affecting the uncertainty of the results. One individual evaluated the quality and risk of bias of all of the studies using the ELIS framework.

Data analysis

A meta-analysis was performed to assess the effect of RBC transfusions on oxygen delivery and cellular metabolism in critically ill septic patients. In addition, this meta-analysis attempted to assess the effect of volume expansion after RBC transfusions in the same population. Therefore, the percentage of SvO₂, O₂ER ratios, cardiac index and microcirculatory parameters were collected as continuous data. The analysis was restricted to available data collected within the systematic review.

Mean differences and 95% confidence intervals (95%CI) were pooled to estimate statistically significant differences before and after RBC transfusions in these critically ill septic patients. All meta-analyses were performed using a random-effects model (DerSimonian and Laird). Heterogeneity was evaluated using meta-regression estimates of between-study variance proportion of residual variation with the Knapp-Hartung modification (I-square test); heterogeneity was classified as low (I-square < 25%), medium (I-square = 25 - 75%), and high (I-square > 75%). Funnel plot asymmetry and Egger's test for small-study effects were performed using meta-regressions to examine whether the results of the meta-analyses may have been affected by publication bias or by the studies' Level of Evidence. P-values < 0.05 were considered statistically significant. All analyses were performed using Stata (version 15) software.

RESULTS

Characteristics of the included studies

Nine hundred eighty-seven (987) manuscripts published between July 1968 and July 2019 were obtained after entering keywords in the MEDLINE^®, Embase and Scopus search boxes. Twenty-four full-text articles were assessed for eligibility; of these, 5 articles were excluded because of a mixed population of septic and nonseptic patients. Nineteen studies comprising data from 428 patients before and after RBC transfusions were finally included in the qualitative and quantitative analyses (Figure 1). The general characteristics of these studies are presented in tables 3SA, 3SB, 3SC, 4SA and 4SB (Supplementary material).

Figure 1
Study selection.

Data from the subgroup analysis performed by Gilbert et al.,⁽²⁴⁾ Silverman et al.,⁽²⁵⁾ Sadaka et al.,⁽²⁶⁾ and Mazza et al.⁽¹⁴⁾ were abstracted and analyzed separately because we considered that each subgroup represented a different population.

Risk of bias

The Level of Evidence analyzed through the ELIS system revealed that 5 studies met the criteria for level II evidence,^{(11,14,26-28)} 8 studies were classified as level III,^{(12,24,25,29-33)} and the remaining were level IV (Table 5S - Supplementary material).

Outcomes assessment

Mixed venous oxygen saturation

There were 359 patients from 14 studies with information on SvO₂ before and after RBC transfusions. Red blood cell transfusions were associated with an increase in the pooled mean SvO₂ of 3.7% (95%CI, 2.23 - 5.18, p < 0.001) (Table 1, Figure 2A). Nonetheless, heterogeneity was high (I-square = 82%). Funnel plot asymmetry and Egger's test for small-study effects demonstrated a lack of publication bias (p = 0.155) (Figure 1SA - Supplementary material). No significant differences were observed for different Levels of Evidence in the meta-regression analysis (p = 0.334) (Figure 2SA - Supplementary material).

Table 1
Unstandardized mean differences in mixed venous oxygen saturation, oxygen extraction ratio, cardiac index and microcirculatory parameters before and after red blood cell transfusions

Outcome	Number of studies	Number of patients	Weight mean difference (95%CI)	p value	I-squared (%)
Unstandardized mean differences in SvO2	14	359	3.71 (2.23 - 5.18)	< 0.001	82
Unstandardized mean differences in O2ER	8	148	-6.98 (-11.39 - -2,57)	< 0.001	82
Unstandardized mean differences in CI	7	198	0.02 (-0.08 - 0.11)	0.96	0
Unstandardized mean differences in thenar tissue oxygen	5	69	1.13 (-1.14 - 3.40)	0.894	0
Unstandardized mean differences tissue Hb Index	5	69	1.66 (0.05 - 3.26)	0.018	66.6
Unstandardized mean differences in thenar tissue oxygen saturation upslope of the reperfusion phase	5	69	0.17 (-0.22 - 0.55)	0.822	0
Unstandardized mean differences in thenar tissue oxygen saturation downslope	4	48	0.56 (-0.41 - 1.54)	0.933	0
Unstandardized mean differences in proportion of perfused small vessels (%)	5	76	2.85 (1.22 - 4.47)	0.553	0
Unstandardized mean differences in pPerfused small vessel density (mm/mm2)	5	76	1.19 (-0.58 - 2.96)	0.044	59.2

• 95%CI - 95% of confidence interval; SvO₂ - mixed venous oxygen saturation; O2ER - oxygen extraction ratio; CI - cardiac index; Hb - hemoglobin.

Figure 2
Unstandardized mean differences.

Oxygen extraction ratio

There were 148 patients from 8 studies with information on O₂ER before and after RBC transfusions. In the meta-analysis, pooled mean differences demonstrated a statistically significant decrease in the O₂ER of -6.98 (95%CI, -11.39 - -2.57; p < 0.001) (Table 1, Figure 2B). Again, the heterogeneity was high (I-squared = 82%). Funnel plot asymmetry and Egger's test for small-study effects demonstrated a lack of publication bias (p = 0.674) (Figure 1SB - Supplementary material). No significant differences were observed for different levels of evidence in the meta-regression analysis (p = 0.171) (Figure 2SB - Supplementary material).

Cardiac index

There were 198 patients from seven studies with information on the cardiac index before and after RBC transfusions. In summary, all of the studies reported similar cardiac indexes before and after RBC transfusions (Table 6S - Supplementary material). The pooled mean difference in the cardiac index before and after RBC transfusion was 0.02 (95%CI -0.08 - 0.11, p = 0.96) (Table 1, Figure 2C), while the heterogeneity was low (0.0%). Funnel plot asymmetry and Egger's test for small-study effects demonstrated a lack of publication bias (p = 0.518) (Figure 1SC - Supplementary material). No significant differences were observed for different Levels of Evidence in the meta-regression analysis (p = 0.436) (Figure 2SC - Supplementary material).

There were 75 patients in which SvO₂, O₂ER, and cardiac index were simultaneously measured. The pooled mean difference of SvO₂ in this group demonstrated a statistically significant SvO₂ increase of 3.71% (95%CI 2.12 - 5.29; p = 0.074; I-square=53.1%), a statistically significant decrease in O₂ER of -3.83 (95%CI -5.26 - -2.39; p = 0.076; I-square = 52.7%), and a pooled mean difference in CI of 0.05 (95%CI -0.06 - 0.15; p = 0.096; I-square = 0.0%) (Figure 3). Funnel plot asymmetry and Egger's test for small-study effects demonstrated a lack of publication bias (Figure 3S - Supplementary material). No significant differences were observed for different Levels of Evidence in the meta-regression analysis (Figure 4S - Supplementary material).

Figure 3
Unstandardized mean differences.

Near infrared spectroscopy

A group of 69 patients were measured for StO₂, THI, upslope reperfusion StO2 and downslope StO2. Thenar tissue oxygen saturation revealed a pooled mean difference of 1.13% (95%CI -1.14 - 3.40; p = 0.894; I-square = 0.0%) and an increase in THI of 1.66 (95%CI 0.05 - -3.26; p = 0.018; I-square = 66.6%) after RBC transfusion. Meanwhile, the pooled mean difference in the up- and downslopes of StO₂ during reperfusion did not show significant variations after RBC transfusion (Table 1, Figure 4).

Figure 4
Unstandardized mean differences.

Creteur et al.⁽¹³⁾ calculated the NIRS-derived tissue oxygen consumption (NIRS VO₂) before and after RBC transfusions (∆NIRS VO₂). In this study, RBC transfusion did not globally affect NIRS-derived variables. However, ∆NIRS VO₂ had a weak but significant relationship with the ΔStO₂ upslope during the reperfusion phase (r2 = 0.14; p = 0.038). In addition, ΔStO₂ upslope during the reperfusion phase had a negative correlation with the baseline StO₂ upslope (r2 = 0.42; p < 0.0001) (Table 6S - Supplementary material).

Similarly, another study⁽¹¹⁾ demonstrated that RBC transfusion did not globally affect NIRS-derived variables, although ∆NIRS VO₂ was negatively correlated with the baseline (r = -0.679, p = 0.001). In addition, there was a positive correlation between ∆NIRS VO₂ and the % change in the StO₂ recovery upslope (r = 0.442, p = 0.045) (Table 6S - Supplementary material).

Sublingual microcirculation

A group of 76 patients were measured for the PPV and the density of small vessels perfused or their functional capillary density (FCD), either by SDF or OPS techniques. The PPV revealed a significant increase of 2.85% (95%CI 1.22 - 4.47; p = 0.553; I-square = 0.0%), while the FCD showed a significant increase of 1.19 (95%CI -0.58 - 2.96; p = 0.044; I-square = 59.2%) (Table 1, Figure 5).

Figure 5
Unstandardized mean differences.

Sakr et al.⁽¹²⁾ described the evolution of microcirculatory variables before and after RBC transfusion in patients with normal versus altered capillary perfusion at baseline. In this study, patients with abnormal capillary perfusion at baseline had a greater and significant increase in PPV (4.5 [3.6 - 4.9] to 4.8 [3.6 - 4.9], p < 0.05, versus 5.2 [4.3 - 5.7] to 5.1 [4.4 - 5.7], p > 0.05) and FCD (2.7 [1.9 - 3.0] to 3.2 [2.7 - 3.9], p < 0.01, versus 3.5 [3.2 - 4.5] to 3.3 [3.0 - 3.8], p > 0.05) than patients with normal microcirculation at baseline (Table 6S - Supplementary material).

DISCUSSION

This systematic review and meta-analysis suggests there are positive effects of RBC transfusions on metabolic oxygen variables (SvO₂ and O₂ER) in patients with sepsis and septic shock, with apparent independence from macrocirculatory changes. Additionally, RBC transfusions positively impact microcirculation and tissue oxygen consumption, especially when the microcirculation and/or tissue VO₂ are altered at baseline. Although RBC transfusions globally increased THI, it was not possible to demonstrate a significant impact on StO₂ or microvascular vasoreactivity variables. Most papers included in this review and meta-analysis used Hb levels as a transfusion trigger, but remarkably, the studies using low SvO₂ or altered tissue perfusion signs to trigger RBC transfusion were those demonstrating the maximal benefit on oxygen metabolic parameters and microvascular blood flow.

Traditionally, Hb levels have been proposed as triggers for RBC transfusion.^(5-10) In fact, conservative transfusion strategies are based on the assumption that maintaining a minimal Hb level should ensure adequate oxygen transport to tissues and thus adequate cell metabolism. Data coming from animal experimental models suggest that extreme hemodilution is well tolerated until Hb concentrations fall to 30 or 50g/L, when depressed left ventricular function and ischemic electrocardiographic changes occur, respectively.⁽³⁴⁾ Similar results were obtained in resting healthy volunteers subjected to acute isovolemic hemodilution up to Hb concentrations of 50g/L,⁽³⁵⁾ suggesting a good tolerance to hemodilution anemia in a wide range of Hb levels. However, such tolerance is not as good in the presence of coronary stenosis, with myocardial ischemia signs appearing earlier.

Clinical evidence revealed that restrictive transfusion strategies could be as safe as liberal practices, except in patients with myocardial ischemia.⁽⁵⁾ Consequently, restricted transfusion became a standard of care in the intensive care unit. However, only the Transfusion Requirements in Septic Shock trial⁽⁹⁾ compared restrictive versus liberal strategies of RBC transfusion in septic patients, demonstrating no significant differences in mortality at day 90. Nevertheless, previously transfused patients were excluded, which reduces its external validity.⁽⁹⁾ Alternatively, observational studies about the impact of RBC transfusion in septic patients reveal contradictory results on clinical outcomes.^(36-39) Nevertheless, no physiological oxygen metabolic parameters were the studied outcomes in any of these studies.

Triggering RBC transfusion based on Hb levels could be misleading since oxygen delivery should be adapted according to the metabolic state and clinical condition.⁽¹⁴⁾ In fact, transfusions performed in the TRISS trial⁽⁹⁾ and other cohort studies^(36-38) were mostly triggered by Hb levels and were not restricted to the early stages of resuscitation, which probably hampered any potential benefit of RBC transfusion. Our results suggest that RBC transfusions could be favorable when abnormal oxygen metabolic parameters are previously altered. Unfortunately, data from our meta-analysis are not able to clarify whether patients showing improvements in oxygen variables would eventually have some clinical outcome benefit.

Early studies suggested that blood transfusions increased oxygen delivery to the tissues in septic patients.^(24,40) However, subsequent papers failed to demonstrate significant increases in SvO₂ following RBC transfusion.^(30,41-44) Nevertheless, blood transfusions are recommended as a therapeutic intervention to increase SvO₂ when other strategies fail to do so.⁽⁴⁵⁾ Resuscitation bundles incorporated into early goal-directed protocols (EGDT) included RBC transfusions as a therapeutic intervention aiming to achieve SvO₂ > 70%. While an initial study of EGDT demonstrated a favorable impact on mortality rates,⁽¹⁵⁾ later studies were not able to demonstrate any significant benefit.^(16-18) However, rates of RBC transfusion in these studies were relatively low: 8.8% versus 3.8% for EDGT versus control in the ProMISe trial;⁽¹⁶⁾ 13.6% versus 7.0% for EDGT versus control in the ARISE trial,⁽¹⁷⁾ and 14.4% versus 7.5% for EDGT versus control in the ProCESS trial.⁽¹⁸⁾ Furthermore, the SvO₂ reported at baseline in the EGDT groups was 70%, 73% and 71% in the ProMISe, ARISE and ProCESS studies, respectively.⁽⁴⁶⁾ Even when very early phases of septic shock are considered, these last few clinical trials were not able to identify patients potentially benefiting from a higher transfusion threshold.

Although hematocrit levels could positively affect oxygen transport (DO₂) at a macrocirculatory level, i.e., improving SvO₂ and O₂ER variables, it remains unclear how an increased hematocrit could influence microcirculatory DO₂.^(47-49) Some authors have suggested that microcirculatory stagnation and impaired DO₂ to the tissues might be closely related to hematocrit variations, theorizing that normovolemic hemodilution can improve microcirculation and DO₂,^(47,50) while others have suggested the limited effects of the hematocrit on microcirculation.⁽⁵¹⁾ Nevertheless, recent observations in experimental septic shock demonstrated a close relationship between microvascular blood flow distribution at the jejunal villi and the dynamic variations of regional mesenteric O₂ER, thus suggesting a close link between microvascular blood flow distribution and tissue oxygenation during the early stages of septic shock.⁽⁵²⁾ Additionally, other observations suggest that RBC transfusions positively impact the lactate/pyruvate ratio in septic patients.⁽⁵³⁾

Red blood cell transfusions globally improve microcirculation by increasing convective blood flow. Interestingly, this effect is more evident when the baseline microcirculatory perfusion is more altered.⁽¹²⁾ Accordingly, oxygen tissue consumption was improved after RBC transfusion only among patients with low NIRS-VO₂ or altered microvascular reactivity at baseline.^(11,13) Nevertheless, data on tissue oxygen variables after RBC transfusion are scarce, and our conclusions are based on a limited number of patients.

Finally, some studies investigated the effect of RBC transfusion according to storage and leukocyte reduction. Although, in general, no differences in microvascular perfusion were observed between leukodepleted and non-leukodepleted RBC transfusions, the microvascular flow index and blood flow velocity showed some superiority with leukodepleted RBCs, suggesting a possible beneficial effect of this modality on convective flow in the microcirculation. A secondary analysis of this study⁽³³⁾ described how transfusion of fresh versus old RBCs had a positive and significant impact on NIRS-derived microcirculatory parameters in septic patients. However, neither fresh nor old RBCs improved sublingual microcirculation following transfusion.⁽³³⁾

Our systematic review and meta-analysis has important limitations. First, we did not have access to the original raw data, so this meta-analysis used the data reported in each of the papers included. Consequently, regrouping patients into more biologically plausible subgroups was not possible. Second, our study has the same "baseline risk" as the pooled research analysis, in which patients with different risks may fare differently when exposed to the same intervention. In our case, it is impossible to determine whether RBC transfusion could have better benefits since the baseline characteristics of sepsis and septic shock differed widely among studies. Nevertheless, most studies agreed that the more altered the microcirculatory blood flow and the lower the NIRS-VO₂ were, the more beneficial RBC transfusion was. Third, our conclusions are entirely based on studies with considerable heterogeneity in which RBCs were presupposed to be beneficial. Fourth, even though our data suggest a potential biological benefit mediated by RBC transfusions, they do not support the idea that improving oxygen metabolic parameters or microcirculatory convective flow can modify clinical outcomes in septic shock.

CONCLUSION

Red blood cell transfusions seem to improve systemic oxygen metabolism in patients with sepsis and septic shock, with apparent independence from cardiac index variations. Red blood cell transfusions apparently improve some tissue oxygenation and microcirculation parameters, particularly in patients with baseline abnormalities. More studies are necessary to evaluate their clinical impact and to individualize transfusion decisions.

ACKNOWLEDGEMENTS

Special acknowledgement to members of the Clinical Investigation Center of Hospital Fundación Valle del Lili (Cali, Colombia), who provided general support, reviewed the article and gave valuable suggestions for the final manuscript

• AVAILABILITY OF DATA AND MATERIALS
  The dataset supporting the conclusions of this article is included within the article (and its additional files).
• FUNDING
  This study was funded by the Clinical Investigation Center of Hospital Fundación Valle del Lili (Cali, Colombia). This institution did not participate in the conception, design, data collection process or writing of the final manuscript.

REFERÊNCIAS

• ¹
  Nelson AH, Fleisher LA, Rosenbaum SH. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med. 1993;21(6):860-6.
• ²
  Hébert PC, Wells G, Tweeddale M, Martin C, Marshall J, Pham B, et al. Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med. 1997;155(5):1618-23.
• ³
  Rohde JM, Dimcheff DE, Blumberg N, Saint S, Langa KM, Kuhn L, et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA. 2014;311(13):1317-26.
• ⁴
  Carson JL, Duff A, Poses RM, Berlin JA, Spence RK, Trout R, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996;348(9034):1055-60.
• ⁵
  Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340(6):409-17.
• ⁶
  Bracey AW, Radovancevic R, Riggs SA, Houston S, Cozart H, Vaughn WK, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion. 1999;39(10):1070-7.
• ⁷
  Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010;304(14):1559-67.
• ⁸
  Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, Nemo G, Dragert K, Beaupre L, Hildebrand K, Macaulay W, Lewis C, Cook DR, Dobbin G, Zakriya KJ, Apple FS, Horney RA, Magaziner J; FOCUS Investigators. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011;365(26):2453-62.
• ⁹
  Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, Johansson PI, Aneman A, Vang ML, Winding R, Nebrich L, Nibro HL, Rasmussen BS, Lauridsen JR, Nielsen JS, Oldner A, Pettilä V, Cronhjort MB, Andersen LH, Pedersen UG, Reiter N, Wiis J, White JO, Russell L, Thornberg KJ, Hjortrup PB, Müller RG, Møller MH, Steensen M, Tjäder I, Kilsand K, Odeberg-Wernerman S, Sjøbø B, Bundgaard H, Thyø MA, Lodahl D, Mærkedahl R, Albeck C, Illum D, Kruse M, Winkel P, Perner A; TRISS Trial Group; Scandinavian Critical Care Trials Group. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014;371(15):1381-91.
• ¹⁰
  Villanueva C, Colomo A, Bosch A, Concepción M, Hernandez-Gea V, Aracil C, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11-21.
• ¹¹
  Sadaka F, Aggu-Sher R, Krause K, O'Brien J, Armbrecht ES, Taylor RW. The effect of red blood cell transfusion on tissue oxygenation and microcirculation in severe septic patients. Ann Intensive Care. 2011;1(1):46.
• ¹²
  Sakr Y, Chierego M, Piagnerelli M, Verdant C, Dubois MJ, Koch M, et al. Microvascular response to red blood cell transfusion in patients with severe sepsis. Crit Care Med. 2007;35(7):1639-44.
• ¹³
  Creteur J, Neves AP, Vincent JL. Near-infrared spectroscopy technique to evaluate the effects of red blood cell transfusion on tissue oxygenation. Crit Care. 2009;13 Suppl 5:S11.
• ¹⁴
  Mazza BF, Freitas FG, Barros MM, Azevedo LC, Machado FR. Blood transfusions in septic shock: is 7.0 g/dL really the appropriate threshold? Rev Bras Ter Intensiva. 2015;27(1):36-43.
• ¹⁵
  Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368-77.
• ¹⁶
  Mouncey PR, Power GS, Coats TJ. Early, Goal-Directed Resuscitation for Septic Shock. N Engl J Med. 2015;373(6):577-8.
• ¹⁷
  ARISE Investigators; ANZICS Clinical Trials Group, Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, Cooper DJ, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371(16):1496-506.
• ¹⁸
  ProCESS Investigators, Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, Pike F, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683-93.
• ¹⁹
  Vincent JL, Jaschinski U, Wittebole X, Lefrant JY, Jakob SM, Almekhlafi GA, Pellis T, Tripathy S, Rubatto Birri PN, Sakr Y; ICON Investigators. Worldwide audit of blood transfusion practice in critically ill patients. Crit Care. 2018;22(1):102.
• ²⁰
  Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G, Peres-Bota D; ABC (Anemia and Blood Transfusion in Critical Care) Investigators. Anemia and blood transfusion in critically ill patients. JAMA. 2002;288(12):1499-507.
• ²¹
  Higgins J, Green S, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]: The Cochrane Collaboration; 2011. Available from: https://handbook-5-1.cochrane.org/
  » https://handbook-5-1.cochrane.org/
• ²²
  Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
• ²³
  Sauaia A, Moore EE, Crebs JL, Maier RV, Hoyt DB, Shackford SR. Evidence level of individual studies: a proposed framework for surgical research. J Trauma Acute Care Surg. 2012;72(6):1484-90.
• ²⁴
  Gilbert EM, Haupt MT, Mandanas RY, Huaringa AJ, Carlson RW. The effect of fluid loading, blood transfusion, and catecholamine infusion on oxygen delivery and consumption in patients with sepsis. Am Rev Respir Dis. 1986;134(5):873-8.
• ²⁵
  Silverman HJ, Tuma P. Gastric tonometry in patients with sepsis. Effects of dobutamine infusions and packed red blood cell transfusions. Chest. 1992;102(1):184-8.
• ²⁶
  Sadaka F, Trottier S, Tannehill D, Donnelly PL, Griffin MT, Bunaye Z, et al. Transfusion of red blood cells is associated with improved central venous oxygen saturation but not mortality in septic shock patients. J Clin Med Res. 2014;6(6):422-8.
• ²⁷
  Mark DG, Morehouse JW, Hung YY, Kene MV, Elms AR, Liu V, et al. In-hospital mortality following treatment with red blood cell transfusion or inotropic therapy during early goal-directed therapy for septic shock: a retrospective propensity-adjusted analysis. Crit Care. 2014;18(5):496.
• ²⁸
  Fernandes CJ Jr, Akamine N, De Marco FV, De Souza JA, Lagudis S, Knobel E. Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients. Crit Care. 2001;5(6):362-7.
• ²⁹
  Donati A, Damiani E, Luchetti M, Domizi R, Scorcella C, Carsetti A, et al. Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study. Crit Care. 2014;18(1):R33.
• ³⁰
  Steffes CP, Bender JS, Levison MA. Blood transfusion and oxygen consumption in surgical sepsis. Crit Care Med. 1991;19(4):512-7.
• ³¹
  Ronco JJ, Phang PT, Walley KR, Wiggs B, Fenwick JC, Russell JA. Oxygen consumption is independent of changes in oxygen delivery in severe adult respiratory distress syndrome. Am Rev Respir Dis. 1991;143(6):1267-73.
• ³²
  Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA. 1993;269(23):3024-9.
• ³³
  Damiani E, Adrario E, Luchetti MM, Scorcella C, Carsetti A, Mininno N, et al. Plasma free hemoglobin and microcirculatory response to fresh or old blood transfusions in sepsis. PLoS One. 2015;10(5):e0122655.
• ³⁴
  Wilkerson DK, Rosen AL, Sehgal LR, Gould SA, Sehgal HL, Moss GS. Limits of cardiac compensation in anemic baboons. Surgery. 1988;103(6):665-70.
• ³⁵
  Leung JM, Weiskopf RB, Feiner J, Hopf HW, Kelley S, Viele M, et al. Electrocardiographic ST-segment changes during acute, severe isovolemic hemodilution in humans. Anesthesiology. 2000;93(4):1004-10.
• ³⁶
  Perner A, Smith SH, Carlsen S, Holst LB. Red blood cell transfusion during septic shock in the ICU. Acta Anaesthesiol Scand. 2012;56(6):718-23.
• ³⁷
  Rosland RG, Hagen MU, Haase N, Holst LB, Plambech M, Madsen KR, et al. Red blood cell transfusion in septic shock - clinical characteristics and outcome of unselected patients in a prospective, multicentre cohort. Scand J Trauma Resusc Emerg Med. 2014;22:14.
• ³⁸
  Parsons EC, Hough CL, Seymour CW, Cooke CR, Rubenfeld GD, Watkins TR; NHLBI ARDS Network. Red blood cell transfusion and outcomes in patients with acute lung injury, sepsis and shock. Crit Care. 2011;15(5):R221.
• ³⁹
  Park DW, Chun BC, Kwon SS, Yoon YK, Choi WS, Sohn JW, et al. Red blood cell transfusions are associated with lower mortality in patients with severe sepsis and septic shock: a propensity-matched analysis. Crit Care Med. 2012;40(12):3140-5.
• ⁴⁰
  Ronco JJ, Montaner JS, Fenwick JC, Ruedy J, Russell JA. Pathologic dependence of oxygen consumption on oxygen delivery in acute respiratory failure secondary to AIDS-related Pneumocystis carinii pneumonia. Chest. 1990;98(6):1463-6.
• ⁴¹
  Conrad SA, Dietrich KA, Hebert CA, Romero MD. Effect of red cell transfusion on oxygen consumption following fluid resuscitation in septic shock. Circ Shock. 1990;31(4):419-29.
• ⁴²
  Lorente JA, Landín L, De Pablo R, Renes E, Rodríguez-Díaz R, Liste D. Effects of blood transfusion on oxygen transport variables in severe sepsis. Crit Care Med. 1993;21(9):1312-8.
• ⁴³
  Gramm J, Smith S, Gamelli RL, Dries DJ. Effect of transfusion on oxygen transport in critically ill patients. Shock. 1996;5(3):190-3.
• ⁴⁴
  Mazza BF, Machado FR, Mazza DD, Hassmann V. Evaluation of blood transfusion effects on mixed venous oxygen saturation and lactate levels in patients with SIRS/sepsis. Clinics (Sao Paulo). 2005;60(4):311-6.
• ⁴⁵
  Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36(1):296-327.
• ⁴⁶
  De Backer D, Vincent JL. Early goal-directed therapy: do we have a definitive answer? Intensive Care Med. 2016;42(6):1048-50.
• ⁴⁷
  Messmer K, Lewis DH, Sunder-Plassmann L, Klövekorn WP, Mendler N, Holper K. Acute normovolemic hemodilution. Changes of central hemodynamics and microcirculatory flow in skeletal muscle. Eur Surg Res. 1972;4(1):55-70.
• ⁴⁸
  Messmer K, Kreimeier U, Intaglietta M. Present state of intentional hemodilution. Eur Surg Res. 1986;18(3-4):254-63.
• ⁴⁹
  Messmer KF. Acceptable hematocrit levels in surgical patients. World J Surg. 1987;11(1):41-6.
• ⁵⁰
  Mirhashemi S, Messmer K, Intaglietta M. Tissue perfusion during normovolemic hemodilution investigated by a hydraulic model of the cardiovascular system. Int J Microcirc Clin Exp. 1987;6(2):123-36.
• ⁵¹
  Sarelius IH. Microcirculation in striated muscle after acute reduction in systemic hematocrit. Respir Physiol. 1989;78(1):7-17.
• ⁵²
  Ospina-Tascón GA, García Marin AF, Echeverri GJ, Bermudez WF, Madriñán-Navia H, Valencia JD, et al. Effects of dobutamine on intestinal microvascular blood flow heterogeneity and O2 extraction during septic shock. J Appl Physiol (1985). 2017;122(6):1406-17.
• ⁵³
  Kopterides P, Theodorakopoulou M, Nikitas N, Ilias I, Vassiliadi DA, Orfanos SE, et al. Red blood cell transfusion affects microdialysis-assessed interstitial lactate/pyruvate ratio in critically ill patients with late sepsis. Intensive Care Med. 2012;38(11):1843-50.

Edited by

Responsible editor: Luciano César Pontes de Azevedo

Data availability

https://minio.scielo.br/documentstore/1982-4335/6fFby7brwYtVSqjPhPpTh8D/d178af38c5a4835d4fe58a6ceb0f22ec6f6fc42e.pdf

Publication Dates

• Publication in this collection
  19 Apr 2021
• Date of issue
  Jan-Mar 2021

History

• Received
  15 Oct 2019
• Accepted
  05 May 2020